Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike Wenzel

Showing results (61-70 of 213) with videos related to

Pageof 22
Sort By:
Urologia Internationalis|January 6, 2021
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in UrologyHendrik Borgmann, Julian P Struck, Angelika Mattigk, et al.
World Journal of Urology|March 24, 2026
Influence of concomitant distant lymph node metastases in metastatic hormone-sensitive prostate cancer patients with bone metastasesMike Wenzel, Benedikt Lauer, Vincenzo Giuseppe Mühlthaler, et al.
European Urology Open Science|July 22, 2024
Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer PatientsMike Wenzel, Carolin Siech, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care CenterBenedikt Hoeh, Mike Wenzel, Clara Humke, et al.
Frontiers in Surgery|November 26, 2020
The Effect of Adverse Patient Characteristics on Perioperative Outcomes in Open and Robot-Assisted Radical ProstatectomyMike Wenzel, Felix Preisser, Lena H Theissen, et al.
European Urology Focus|March 19, 2021
Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical NephroureterectomyClaudia Collà Ruvolo, Luigi Nocera, L Franziska Stolzenbach, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
Journal of Imaging Informatics in Medicine|June 26, 2024
Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate CancerAndreas Michael Bucher, Jan Egger, Julia Dietz, et al.
Minerva Urology and Nephrology|June 18, 2025
Transforming hostile abdomen management: the rise of single-port for retroperitoneal robot-assisted partial nephrectomyAngelo Mottaran, Federico Piramide, Paolo Dell'oglio, et al.
Pageof 22

Showing results (61-70 of 213) with videos related to

Sort By:
Pageof 22
Urologia Internationalis|January 6, 2021
Increased Severe Adverse Outcomes and Decreased Emergency Room Visits for Pyelonephritis: First Report of Collateral Damage during COVID-19 Pandemic in UrologyHendrik Borgmann, Julian P Struck, Angelika Mattigk, et al.
World Journal of Urology|March 24, 2026
Influence of concomitant distant lymph node metastases in metastatic hormone-sensitive prostate cancer patients with bone metastasesMike Wenzel, Benedikt Lauer, Vincenzo Giuseppe Mühlthaler, et al.
European Urology Open Science|July 22, 2024
Contemporary Treatment Patterns and Oncological Outcomes of Metastatic Hormone-sensitive Prostate Cancer and First- to Sixth- line Metastatic Castration-resistant Prostate Cancer PatientsMike Wenzel, Carolin Siech, Benedikt Hoeh, et al.
Diagnostics (Basel, Switzerland)|June 19, 2024
Transition from Transrectal to Transperineal MRI-Fusion Prostate Biopsy Does Not Comprise Detection Rates of Clinically Significant Prostate Cancer at a Tertiary Care CenterBenedikt Hoeh, Mike Wenzel, Clara Humke, et al.
Frontiers in Surgery|November 26, 2020
The Effect of Adverse Patient Characteristics on Perioperative Outcomes in Open and Robot-Assisted Radical ProstatectomyMike Wenzel, Felix Preisser, Lena H Theissen, et al.
European Urology Focus|March 19, 2021
Tumor Size Predicts Muscle-invasive and Non-organ-confined Disease in Upper Tract Urothelial Carcinoma at Radical NephroureterectomyClaudia Collà Ruvolo, Luigi Nocera, L Franziska Stolzenbach, et al.
JCO Precision Oncology|December 6, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With <i>BRCA</i> Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand TherapyMike Wenzel, Florestan Koll, Benedikt Hoeh, et al.
Urologic Oncology|January 24, 2025
Association between frailty and specific comorbidities on oncological outcomes in metastatic hormone-sensitive and castration resistant prostate cancerMike Wenzel, Benedikt Hoeh, Carolin Siech, et al.
Journal of Imaging Informatics in Medicine|June 26, 2024
Value of MRI - T2 Mapping to Differentiate Clinically Significant Prostate CancerAndreas Michael Bucher, Jan Egger, Julia Dietz, et al.
Minerva Urology and Nephrology|June 18, 2025
Transforming hostile abdomen management: the rise of single-port for retroperitoneal robot-assisted partial nephrectomyAngelo Mottaran, Federico Piramide, Paolo Dell'oglio, et al.
Pageof 22